Ranked #3,958 of 8,699 institutional investors
Prosight Management, LP
Dallas, TX
$439M
US stock portfolio at live prices · today +$2.9M (+0.67%)
Market closed. Prices as of Nov 20, 6:11 AM ET
- Value at quarter end (Q3 2026)
- $515M
- Change from Q2 2026
- −$64.9M (−11.18%)
- Positions
- 30 · 9 new, 11 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$22.8M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesLKFT 15.2%STTK 7.92%INSM 7.83%ABVX 6.92%JANX 6.90%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| LKFT Lakefront Biotherapeutics NV | 1,998,400 | $66.7M | 15.2% | Reduced −2% |
| STTK Shattuck Labs, Inc. | 7,648,094 | $34.8M | 7.92% | Added +28% |
| INSM Insmed Incorporated | 238,088 | $34.4M | 7.83% | Reduced −37% |
| ABVX ABIVAX Société Anonyme | 376,794 | $30.4M | 6.92% | Added +251% |
| JANX Janux Therapeutics, Inc. | 2,943,200 | $30.3M | 6.90% | Reduced −23% |
| PRVA Privia Health Group, Inc. | 1,049,752 | $25.9M | 5.90% | New |
| NKTR Nektar Therapeutics | 785,000 | $25.5M | 5.82% | Reduced −3% |
| BSX Boston Scientific Corporation | 550,000 | $23.6M | 5.38% | Reduced −57% |
| ZYME Zymeworks Inc. | 721,100 | $19.4M | 4.41% | Added +7% |
| IRTC iRhythm Holdings, Inc. | 200,980 | $18.9M | 4.31% | Added +21% |
| BBIO BridgeBio Pharma, Inc. | 150,000 | $11.7M | 2.67% | New |
| MLYS Mineralys Therapeutics, Inc. | 800,000 | $11.3M | 2.58% | Added +78% |
| PRAX Praxis Precision Medicines, Inc. | 36,400 | $11.3M | 2.58% | New |
| HQY HealthEquity, Inc. | 115,796 | $11.3M | 2.57% | New |
| DNLI Denali Therapeutics Inc. | 550,700 | $10.0M | 2.28% | New |
| KURA Kura Oncology, Inc. | 1,275,000 | $9.4M | 2.13% | Reduced −37% |
| HUM Humana Inc. | 22,000 | $8.4M | 1.90% | New |
| SNDX Syndax Pharmaceuticals, Inc. | 812,582 | $7.4M | 1.69% | Reduced −32% |
| ENOV Enovis Corporation | 267,432 | $7.0M | 1.60% | New |
| ALNY Alnylam Pharmaceuticals, Inc. | 37,000 | $5.5M | 1.25% | Reduced −62% |
| OKUR OnKure Therapeutics, Inc. | 1,325,570 | $3.7M | 0.83% | Added +35% |
| ANTX AN2 Therapeutics, Inc. | 350,877 | $1.8M | 0.42% | Reduced −26% |
| QTRX Quanterix Corporation | 825,000 | $1.7M | 0.38% | New |
| GENB Generate Biomedicines, Inc. | 144,756 | $1.5M | 0.34% | New |
| RCKT Rocket Pharmaceuticals, Inc. | 595,024 | $1.3M | 0.29% | Reduced −15% |
| PLRX Pliant Therapeutics, Inc. | 1,604,466 | $995K | 0.23% | Added +17% |
| COYA Coya Therapeutics, Inc. | 229,600 | $684K | 0.16% | Added +35% |
| RNTX Rein Therapeutics Inc. | 1,660,197 | $610K | 0.14% | Added +51% |
| IMRX Immuneering Corporation | 150,000 | $518K | 0.12% | Added +307% |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 168,383 | $410K | <0.1% | Reduced −74% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| VEEV Veeva Systems Inc. | 106,200 | $27.9M |
| ICUI ICU Medical, Inc. | 51,000 | $9.0M |
| OPCH Option Care Health, Inc. | 270,716 | $8.6M |
| ISRG Intuitive Surgical, Inc. | 17,000 | $6.9M |
| PRCT PROCEPT BioRobotics Corporation | 268,269 | $6.9M |
| KIDS OrthoPediatrics Corp. | 157,500 | $5.1M |
| WGS GeneDx Holdings Corp. | 85,500 | $4.2M |
| PFE Pfizer Inc. | 135,366 | $3.7M |
| EBS Emergent BioSolutions Inc. | 459,952 | $2.4M |
| EFOR Everforth Inc | 67,500 | $2.0M |
| TECX Tectonic Therapeutic, Inc. | 39,731 | $836K |